Andrew Haag
About Andrew Haag
Andrew Haag is the Senior Director of Business & Operational Excellence, Worldwide Patient Safety at Bristol Myers Squibb, with over 20 years of experience in various leadership roles within the company.
Current Title and Role
Andrew Haag is the Senior Director, Business & Operational Excellence, Worldwide Patient Safety at Bristol Myers Squibb. In this role, he focuses on initiatives to enhance operational efficiency and ensure the safety of patients globally.
Career at Bristol Myers Squibb
Andrew Haag has been with Bristol Myers Squibb for over 20 years, serving in various leadership capacities. His roles have spanned from finance to regulatory operations, demonstrating his versatility and expertise. From 2000 to 2004, he served as Manager, Finance, Global Product Development & Supply. He then transitioned to Associate Director, Finance, Research & Development, a role he held until 2011. Following this, he was appointed Director, Business Operations, Global Pharmacovigilance & Epidemiology, where he worked for five years. His subsequent positions included Director, Business Operations, Global Regulatory, Safety & Biometrics, and Senior Director, Business Operations, Global Regulatory & Safety Sciences. He held these roles from 2016 to 2022.
Education and Expertise
Andrew Haag has a robust educational background with a Master of Business Administration (M.B.A.) in Accounting and Finance from NYU Stern School of Business, completed between 1996 and 2000. He also holds a Bachelor of Arts (B.A.) in Economics from Colgate University, attained from 1990 to 1994. His extensive knowledge in both finance and regulatory operations has been foundational to his successful career.
Transition from Finance to Operational Excellence
Andrew Haag transitioned from finance roles to operational excellence over his tenure at Bristol Myers Squibb. Starting in finance, he moved on to roles involving business operations and regulatory safety sciences. This shift underscores his adaptability and extensive skill set in driving business efficiency and ensuring regulatory compliance.
Experience in Regulatory and Safety Sciences
With over two decades of experience at Bristol Myers Squibb, Andrew Haag has developed a thorough understanding of global regulatory, safety, and biometrics operations. His tenure includes pivotal roles where he has been instrumental in advancing business operations and regulatory safety sciences, contributing significantly to the company's mission of ensuring patient safety.